Postsurgical adjuvant therapy for melanoma: Evaluation of a 3-year randomized trial with recombinant interferon-α after 3 and 5 years of follow-up

Cancer

Volumn 79, Issue 12, 1997, Pages 2354-2360

  Rusciani, Luigi ^a,d   Petraglia, Sandra ^a   Alotto, Massimo ^a   Calvieri, Stefano ^b   Vezzoni, Giampaolo ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Department of Dermatology   (Italy)

^d NONE   (Italy)

Author keywords

Adjuvant therapy; Case control; Follow up; Melanoma; Metastasis; Progression; Recombinant interferon

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; FOLLOW-UP STUDIES; HUMANS; INTERFERON ALFA-2B; MELANOMA; MIDDLE AGED; NEOPLASM STAGING;

EID: 0030912391     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2354::AID-CNCR9>3.0.CO;2-L     Document Type: Article

References (34)

1. Gallagher RP, Becky M, McLean DI, Yang CP, Ho V, Carruthers JA, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990;23:413-21.
2. Cascinelli N, Marchesini R. Increasing evidence of cutaneous melanoma, ultraviolet radiation and the clinician. Photochem Photobiol 1989;50(4):497-505.
3. Koh HK. Cutaneous melanoma. N Engl J Med 1991;325:171-82.
4. Skolknick AA. Melanoma epidemics yields grim statistics. JAMA 1991;265(24):3217-8.
5. Roy MA, Wagner RF. Prevention of primary cutaneous malignant melanoma: increasing cure rate in the 1990's. Cutis 1992;50:365-9.
6. Johnson TM, Smith JW II, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995;32(5):689-706.
7. Berwick M, Dubin N, Luo ST, Flannery J. No improvement in survival from melanoma diagnosed from 1973 to 1984. Int J Epidemiol 1994;23(4):673-81.
8. Kokoschka EM, Trautinger F, Knobler RM, Pohl-Markl H, Micksche M. Long-term adjuvant therapy of high risk malignant melanoma with Interferon α-2b. J Invest Dermatol 1990;95:193s-7s.
9. Barth A, Morton DL. The role of adjuvant therapy in melanoma management. Cancer 1995;75(2 Suppl):726-34.
10. Slingluff CJ Jr., Dodge RK, Stanley WE, Seigler HF. The annual risk of melanoma progression. Implications for the concept of cure. Cancer 1992;70:1917-27.
11. Meunier L. Les interférons en dermatologie. Ann Dermatol Venereol 1988;115:1079-89.
12. Aapro MS. Advances in systemic treatment of malignant melanoma. Eur J Cancer 1993;29A(4):613-7.
13. Kirkwood JM, Ernstoff MS. Role of interferons in the therapy of melanoma. J Invest Dermatol 1990;95:180S-4S.
14. Ho VC, Sober AJ. Therapy for cutaneous melanoma: an update. J Am Acad Dermatol 1990;22:159-76.
15. Agarwala SS, Kirkwood JM. Potential use of interferon alpha 2 as adjuvant therapy in cancer. Ann Surg Oncol 1995;2(4):365-71.
16. Luke LG, Tyring SK, Wagner RF. Possible role of adjuvant therapy for thin malignant melanoma. Cutis 1992;50:377-9.
17. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa 2b adjuvant therapy of high risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14(1):7-17.
18. Hahka-Kemppinen M, Mulhonen T, Virolainen M, Jekuken A, Asko-Seljavaara S, Pyrhonen S. Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy. Br J Dermatol 1995;132(6):973-7.
19. Fierlbeck G, Schreiner T, Rassner G. Combination of highly purified human leukocyte interferon alpha and 13-cis-retinoic acid for the treatment of metastatic melanoma. Cancer Immunol Immunother 1995;40(3):157-64.
20. Luger TA, Schwarz T. Therapeutic use of cytokines in dermatology. J Am Acad Dermatol 1991;24:915-26.
21. Legha SW. Interferons in the treatment of malignant melanoma. Cancer 1986;57:1675-7.
22. Mc Leod GR, Thomson DB, Hersey P. Clinical evaluation of interferons in malignant melanoma. J Invest Dermatol 1990;95:185s-7s.
23. Lanza L, Peirano L, Bosco O, Contini P, Filaci G, Serti M, et al. Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones. Cancer Immunol Immunother 1995;41(1):23-8.
24. Krasagakis K, Garbe C, Zouboulis CC, Orfanos CE. Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res 1995;139:169-82.
25. Rodriguez-Villanueva J, McDonnell TJ. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int J Cancer 1995;61(1):110-4.
26. Baron S, Tyring SK, Fleischmann WR, Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons: mechanisms of action and clinical application. JAMA 1991;266:1375-83.
27. Linge C, Gewert D, Rossmann C, Bishop JA, Crowe JS. Interferon system defects in human malignant melanoma. Cancer Res 1995;55(18):4099-104.
28. Doveil GC, Fierro MT, Novelli M, Appino A, Bertero M, Quaglino P, et al. Adjuvant therapy of stage IIIb melanoma with Interferon alfa-2b. Clinical and immunological relevance. Dermatology 1995;191:234-9.
29. Cascinelli N, Bufalino R, Morabito A, Mackie R. Results of adjuvant interferon study in WHO melanoma programme. Lancet 1994;343:913-4.
30. Mackie R. Melanoma. Br Med Bull 1995;51(3):656-77.
31. Greenstein DS, Rogers GS. Management of stage I malignant melanoma. Dermatol Surg 1995;21(11):927-37.
32. Dean GE, Spears L, Ferrell BR, Quan WD, Groshon S, Mitchell MS. Fatigue in patients with cancer receiving interferon alpha. Cancer Pract 1995;3(3):164-72.
33. Mansson-Brahme E, Carstensen J, Erhardt K, Lagerlof B, Ringborg U, Rutqvist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994;73(9):2324-32.
34. Trau H, Rigel DS, Harris MN, Kopf AW, Friedman RJ, Gumport SL, et al. Metastases of thin melanoma. Cancer 1983;51:553-6.